Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FS Grifols vs Surgicel in Soft Tissue Surgery
NCT01731938Phase 3Completed
- Sponsor
- Grifols
- Start
- Nov 2012
- Primary completion
- Apr 2015
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, single-blind trial of VISTASEAL (2 arms), sponsored by Grifols. Primary endpoint: Percentage of Subjects Achieving Hemostasis Within 4 Minutes After Treatment Start. Started Nov 2012; status: completed.
02
Drugs
VISTASEAL
Beyond the preview
Go deeper on NCT01731938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01731938.